TTrialPathMatch Me to Trials
← Back to trials
RecruitingHypertension in Pregnancy

Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project

Eligible age

14–89 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The CHAP2 study is designed to provide preliminary data for a larger multicenter study to assess whether treatment of stage 1 hypertension (HTN) in pregnancy improves maternal and or neonatal outcomes. The primary objective of this pilot study is to determine if anti-HTN treatment to BP\<130/80mmHg in pregnant patients with stage 1 HTN is associated with a difference in birthweight percentile at delivery. Patients with stage 1 hypertension in pregnancy will be randomized to BP goals of \<130/80mmHg or usual care to treatment only if BPs ≥140/90mmHg. For this pilot, the investigator will randomize a total of 74 eligible participants, 37 to active treatment to BP\<130/80mmHg and 37 to usual care.

Sponsor: University of Alabama at Birmingham

You may qualify if…

  • ✓ Viable singleton gestation
  • ✓ No fetal anomalies
  • ✓ Blood pressures 130-139/80-89mmHg on two occasions at least 4 hours apart prior to 20 weeks gestation
  • ✓ Planning to deliver at UAB Hospital
  • ✓ No indication for pregnancy termination
  • ✓ Receiving care at the UAB prenatal clinics

You may not qualify if…

  • ✕ Declines Randomization
  • ✕ Known diagnosis of chronic hypertension ( BP ≥ 140/90mmHg) or current antihypertensive medication use
  • ✕ Fetal demise diagnosed prior to enrollment
  • ✕ Known major structural of chromosomal abnormalities prior to enrollment
  • ✕ Contraindication to first line antihypertensive (Nifedipine/ Labetalol)
  • ✕ Comorbidities requiring BP goals \< 130/80mmHg

Where it's recruiting

Alabama

Birmingham

Source: ClinicalTrials.gov · NCT05989581 · last updated 2026-08-11

Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project · TrialPath